The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21.10 - Manufacture of basic pharmaceutical products
New offshoring locations
320 jobs Number of planned job losses
Announcement Date
1 October 2019
Employment effect (start)
1 December 2019
Foreseen end date
1 December 2021
Description
Pharmaceutical company Lek from Ljubljana, a subsidiary of Swiss-based Sandoz group, will cease antibiotic production at its Prevalje plant by late 2021. The production will be offshored to Kundl in Austria, so 250 employees and 70 agency workers will lose their jobs. The site will have a new role as Novartis plans to set up a centre for global operations in Slovenia, carrying out logistics, supply chain, purchasing, quality control, production science, technology and engineering. Novartis has ensured that all employees will be able to requalify.
Eurofound (2019), Lek, Offshoring/Delocalisation in Slovenia, factsheet number 98765, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/98765.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
